Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

October 8, 2026 by Alan Khadavi

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

On October 7, 2026, the FDA approved Rhapsido (remibrutinib) for adults with symptomatic dermographism whose symptoms remain inadequately controlled with H1 antihistamines. As an allergist, I consider this an important development because symptomatic dermographism has historically had remarkably few treatment options. Symptomatic dermographism is a form of chronic inducible urticaria in which scratching, rubbing, pressure […]

Filed Under: Blog, Urticaria

March 10, 2026 by Alan Khadavi

Barzolvolimab: A Breakthrough Treatment Being Studied for Cold Urticaria and Symptomatic Dermographism

Barzolvolimab

Patients with chronic hives often struggle with symptoms that appear without warning. For some individuals, however, hives are triggered by very specific physical stimuli. Two common forms of chronic inducible urticaria are cold-induced urticaria and symptomatic dermographism, both of which can significantly affect daily life. A promising new medication called barzolvolimab is currently being studied […]

Filed Under: Blog, Urticaria

December 15, 2025 by Alan Khadavi

Rhapsido vs Xolair vs Dupixent for Chronic Hives

rhapsido-vs-xolair-vs-dupixent-chronic-hives

Rhapsido vs Xolair vs Dupixent — which targeted treatment is right for chronic hives? Chronic spontaneous urticaria (CSU, “chronic hives”) can be maddening: daily itch, unpredictable wheals, and flares that don’t respond to antihistamines. Over the last few years clinicians have gained new targeted options beyond antihistamines — an injectable anti-IgE (Xolair), an injectable IL-4/13 […]

Filed Under: Blog, Urticaria

October 3, 2025 by Alan Khadavi

Rhapsido (remibrutinib) wins FDA approval for chronic hives

rhapsido

The FDA has just approved Rhapsido® (remibrutinib) — the first oral, targeted Bruton tyrosine kinase (BTK) inhibitor authorized for chronic spontaneous urticaria (CSU) in adults who remain symptomatic despite H1-antihistamines. This is a genuinely new treatment class and — importantly — an oral alternative to biologics. Below I summarize the data, how allergists are likely […]

Filed Under: biologics, Blog, Urticaria

November 3, 2020 by Alan Khadavi

New treatments for chronic hives

rhapsido

New treatments for chronic hives are currently being studied. Chronic urticaria or hives is defined as having urticaria for more than 6 weeks duration. Chronic hives have been called chronic idiopathic urticaria, chronic autoimmune urticaria or chronic spontaneous urticaria. There is also chronic inducible urticaria which can be brought on by cold, delayed pressure, solar, […]

Filed Under: Blog, Urticaria

August 27, 2020 by Alan Khadavi

Chronic Hives work up not essential or cost effective

chronic spontaneous urticaria

Chronic hives or chronic spontaneous urticaria or chronic idiopathic urticaria or chronic autoimmune urticaria is characterized by moving, itching wheals that occur with variable frequency for 6 weeks duration or more. Stepwise approach to Chronic Urticaria (Chronic Hives) It can occur in adults and pediatrics, but it is more common in adults. It is usually […]

Filed Under: Blog, hives, Urticaria

June 13, 2019 by Alan Khadavi

Dupixent for Hives

chronic spontaneous urticaria

Dupixent for hives is novel treatment option for patients with difficult to treatment chronic spontaneous urticaria.  Chronic hives is a common condition marked by episodes of elevated, itching, red wheals persisting for more than 6 weeks without a specific known cause.  It is estimated that chronic hives affects about 1% of the population. The mechanism […]

Filed Under: biologics, Blog, hives, Urticaria

May 2, 2019 by Alan Khadavi

Mast Cell Activation Syndrome (MCAS): Fact & Fiction

mcas

Mast cell activation syndrome (MCAS) is a rare condition defined by a severe systemic reaction to mast cell derived mediators.  Mast cells are effector cells of the immune system.  These cells produce a variety of proinflammatory mediators and participate in a number of different pathological conditions.  In patients the risk of developing severe anaphylactic (hypersensitivity) events […]

Filed Under: Blog, Headlines, Urticaria

April 25, 2019 by Alan Khadavi

Cold Hives (urticaria): A review

cold hives

Cold hives (or urticaria), is a subtype of physical hives that is characterized by the development of hives and swelling in response to cold exposure and rewarming of the skin.  It is related to the histamine release of mast cells.  Several studies have shown that it is related to IgE and an unknown skin autoallergen […]

Filed Under: angioedema, Blog, hives, Urticaria

December 28, 2017 by Alan Khadavi

Severe Hives Treatment (Xolair and Cyclosporine)

new urticaria

Severe hives or chronic spontaneous urticaria is classified as hives with or without swelling that occurs for 6 weeks or more with an unknown cause.  The prevalence of chronic hives (also known as chronic idiopathic urticaria) is approximately 0.5% to 5% of the population.  Chronic hives may be active for 1-5 years at a time, […]

Filed Under: Blog, Urticaria

  • 1
  • 2
  • Next Page »

Latest Posts

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

September 28, 2026

Tyra Banks Cat Allergy: Do Allergy Shots Work?

tyra banks cat alllergy

September 25, 2026

Famous Politicians With Allergies: Presidents and Political Leaders Who Have Battled Allergic Disease

famous politicians with allergies

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page